Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05816564 · ClinicalTrials.gov registry record · NA
Optimizing Attentional Bias Modification
A NA study of Depression, sponsored by University of Texas at Tyler.
- Active
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 1
- Study location
NCT05816564: Active NA study of Depression, sponsored by University of Texas at Tyler.
NCT05816564 is a NA study of Depression that is active but no longer recruiting, run by University of Texas at Tyler. The registered enrollment target is 51 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05816564, a NA study of Depression, is active but no longer recruiting, sponsored by University of Texas at Tyler.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
Depression has been associated with an attention bias towards negative information. Attention bias modification (ABM) interventions explore potential benefits of training attention away from negative or threatening information and towards neutral or positive information. The goal of this study is to examine the effectiveness of an ABM intervention that includes a preceding mindfulness training among a sample of individuals who self-reported mild-to-moderately depression symptoms. The main question this study aims to answer is: • Do individuals who participate in an ABM intervention have a greater reduction in attention bias towards negative information and depressive symptoms when compared to a control group? Participants will be asked to participate in 3 days of brief mindfulness training exercises preceding an ABM intervention session that lasts 1.5 to 2 hours while wearing electroencephalography (EEG) equipment. Researchers will compare the ABM intervention group to a "sham" intervention group to see if the ABM intervention reduces negative attention bias above and beyond brief mindfulness training.
Conditions Studied
Interventions
- BEHAVIORAL Attention Bias Modification (ABM) for depression
- BEHAVIORAL Sham Attention Bias Modification (ABM)
Study Locations (1)
Texas
- The University of Texas at Tyler - Tyler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2022-10-01 |
| Est. Completion | 2024-12-01 |
| Phase | NA |
What the registry record for NCT05816564 still lists
NCT05816564 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Attention Bias Modification (ABM) for depression is the first listed.
NCT05816564 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05816564 about?
NCT05816564 is a clinical study titled "Optimizing Attentional Bias Modification". Depression has been associated with an attention bias towards negative information. Attention bias modification (ABM) interventions explore potential benefits of training attention away from negative or threatening information and towards neutral or positive information. The goal of this study is to...
What is the current status of trial NCT05816564?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 51 participants. The study started on 2022-10-01. Estimated completion is 2024-12-01.
What conditions does trial NCT05816564 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT05816564?
The interventions under investigation include: Attention Bias Modification (ABM) for depression (BEHAVIORAL), Sham Attention Bias Modification (ABM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05816564?
This trial is sponsored by University of Texas at Tyler, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05816564 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05816564's enrollment target sits among peer trials
51 466th of 679 higher than 213 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy